Acasta Enterprises Incorporated

Acasta Enterprises Completes Sale of JemPak and Reduction of its Indebtedness

Acasta Enterprises Inc. (TSX: AEF) (“Acasta” or the “Company”) announced today that it has completed the previously announced sale (the “Transaction”) of JemPak Corporation to a wholly-owned subsidiary of Henkel AG & Co. KGaA.

“With the closing of this Transaction, Acasta has been able to significantly reduce its indebtedness and reduce the associated cost of borrowing on its remaining indebtedness,” commented Ian Kidson, Interim Chief Executive of the Company. “We would like to thank our lenders for their constructive dialogue with us and assistance in implementing the closing of the Transaction.”

The net proceeds from the Transaction of approximately $115 million were used primarily to pay down Acasta’s indebtedness. Acasta has repaid approximately $77.3 million (U.S.$59 million) under its U.S.$150 million credit facility leaving only approximately U.S.$10 million in indebtedness to WFI Inc., an entity controlled by Charles and Richard Wachsberg.

In addition, Acasta has entered into an amending agreement with Canadian Imperial Bank of Commerce whereby it remains as the only lender to Apollo Health and Beauty Care Inc. (“Apollo”) in the amount of approximately $58 million which is secured by a first ranking charge over all property of Apollo as well as a pledge of all equity interests and indebtedness of Apollo held by Acasta. As of the date hereof, the Company’s aggregate indebtedness is approximately $74 million.

Canaccord Genuity Corp. served as financial advisor and Goodmans LLP acted as legal counsel to Acasta, respectively.

EN
01/06/2018

Reports on Acasta Enterprises Incorporated

 PRESS RELEASE

Apollo Healthcare Corp. Reports First Quarter of 2021 Results

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC, OTC QX: AHCCF) (“Apollo” or the “Company”) today announced financial results for the first quarter ended March 31, 2021. The Company’s un-audited interim financial statements for the three months ended March 31, 2021, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Highlights Revenues f...

 PRESS RELEASE

Apollo Healthcare Corp. Reports Fourth Quarter of 2020 Results

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC, OTC QX: AHCCF) (“Apollo” or the “Company”) today announced financial results for the quarter and year ended December 31, 2020. The Company’s audited consolidated financial statements for the three months and year ended December 31, 2020, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Fin...

 PRESS RELEASE

Apollo Healthcare Corp. Commences Process to Join OTC QX Marketplace i...

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp (TSX: AHC) (“Apollo” or the “Company”) is pleased to announce that it will be joining the OTC QX marketplace in the United States. Joining the OTC QX will facilitate trading in Apollo’s securities by U.S. investors. The Company expects to complete the process before the end of its first quarter of 2021 and will update the market once the process is complete. Apollo will maintain its primary listing on the Toronto Stock Exchange. Apollo is also pleased to announce that it has retained the services of Hybrid Financial to heighten market and bran...

 PRESS RELEASE

Apollo Healthcare Corp. Reports Third Quarter of 2020 Results

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (formerly Acasta Enterprises Inc.) (TSX: AHC) (“Apollo” or the “Company”) today announced financial results for the quarter ended September 30, 2020. The Company’s unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2020, as well as its accompanying management discussion and analysis (MD&A) have been filed on SEDAR. Copies of the filings may be obtained at . All values in this news release and the Company’s financial disclosures are in Canadian dollars unless otherwise stated. Finan...

 PRESS RELEASE

Apollo Healthcare Corp. Announces Board of Directors Changes

TORONTO--(BUSINESS WIRE)-- Apollo Healthcare Corp. (TSX: AHC) (“Apollo” or the “Company”) announces that Stan Bharti has stepped down as a director of the Company. Charles Wachsberg has agreed to assume Mr. Bharti’s role as Chair of the Board. “We truly value Mr Bharti’s support and his numerous contributions to our Board as Chair. Mr. Bharti has played a key role in the successful turnaround of our business and we are most appreciative and grateful for his efforts” said Charles Wachsberg. In addition, the Company is pleased to announce the appointment of Andrew Schachter to Apollo’s Board...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch